Revolution Medicines (RVMD) Prepaid Assets (2019 - 2026)
Revolution Medicines' (RVMD) quarterly Prepaid Assets came in at $59.8 million in Q1 2026, up 87.51% year-on-year from $31.9 million in Q1 2025, and up 21.21% quarter-over-quarter from $49.4 million in Q4 2025.
Revolution Medicines (RVMD) Prepaid Assets (2019 - 2026) Analysis & Trends
Revolution Medicines' Prepaid Assets history runs 8 years deep, the most recent figure standing at $59.8 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 87.51% year-over-year to $59.8 million in Q1 2026; TTM through Mar 2026 was $59.8 million, a 87.51% increase from a year earlier, with the FY2025 full-year figure at $49.4 million, up 28.76% from the prior year.
- Prepaid Assets climbed to $59.8 million in Q1 2026 per RVMD's latest filing, from $49.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $59.8 million in Q1 2026 and bottomed at $9.0 million in Q1 2023.
- The 5-year median for Prepaid Assets is $25.7 million (2024), against an average of $27.1 million.
- Across the five-year window, Prepaid Assets sank 36.88% in 2023 and jumped 237.02% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $10.6 million in 2022, then jumped by 137.22% to $25.1 million in 2023, then soared by 52.89% to $38.3 million in 2024, then climbed by 28.76% to $49.4 million in 2025, then advanced by 21.21% to $59.8 million in 2026.
- Per Business Quant, the three latest RVMD Prepaid Assets figures stand at $59.8 million (Q1 2026), $49.4 million (Q4 2025), and $46.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.83 Mn |
| Dec 31, 2025 | 49.36 Mn |
| Sep 30, 2025 | 45.98 Mn |
| Jun 30, 2025 | 39.27 Mn |
| Mar 31, 2025 | 31.91 Mn |
| Dec 31, 2024 | 38.33 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Jun 30, 2024 | 34.02 Mn |
| Mar 31, 2024 | 25.66 Mn |
| Dec 31, 2023 | 25.07 Mn |
| Sep 30, 2023 | 10.96 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 8.96 Mn |
| Dec 31, 2022 | 10.57 Mn |
| Sep 30, 2022 | 15.16 Mn |
| Jun 30, 2022 | 15.99 Mn |
| Mar 31, 2022 | 10.21 Mn |
| Dec 31, 2021 | 6.79 Mn |
| Sep 30, 2021 | 7.47 Mn |
| Jun 30, 2021 | 8.16 Mn |